Detection of cell-free BIRC5 mRNA in effusions and its potential diagnostic value for differentiating malignant and benign effusions

International Journal of Cancer

Volumn 125, Issue 8, 2009, Pages 1921-1925

  Wang, Tingting ^a   Qian, Xiaoping ^a   Wang, Zhongqiu ^b   Wang, Lifeng ^a   Yu, Lixia ^a   Ding, Yitao ^c   Liu, Baorui ^a,c  

^a NANJING UNIVERSITY   (China)

^b MEDICAL SCHOOL OF NANJING UNIVERSITY   (China)

^c Clinical Medical Center for Hepatobiliary Disease in Jiangsu Province   (China)

Author keywords

BIRC5; Cell free mRNA; Diagnosis; Effusion

Indexed keywords

BIOLOGICAL MARKER; BIRC5 PROTEIN; CARCINOEMBRYONIC ANTIGEN; MESSENGER RNA; TUMOR PROTEIN; UNCLASSIFIED DRUG; BIRC5 PROTEIN, HUMAN; MICROTUBULE ASSOCIATED PROTEIN;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; ASCITES; BENIGN EFFUSION; CANCER STAGING; CELL FREE SYSTEM; CYTODIAGNOSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; EFFUSION; FEMALE; GENE EXPRESSION; HUMAN; LUNG NON SMALL CELL CANCER; MALE; MALIGNANT EFFUSION; PLEURA FLUID; PRIORITY JOURNAL; PROSPECTIVE STUDY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; SENSITIVITY ANALYSIS; CELL DIFFERENTIATION; GENETICS; METABOLISM; MIDDLE AGED; NEOPLASM; PLEURA EFFUSION; PROGNOSIS; ROC CURVE; SENSITIVITY AND SPECIFICITY;

ADULT; AGED; AGED, 80 AND OVER; ASCITES; CARCINOEMBRYONIC ANTIGEN; CELL DIFFERENTIATION; FEMALE; HUMANS; MALE; MICROTUBULE-ASSOCIATED PROTEINS; MIDDLE AGED; NEOPLASM STAGING; NEOPLASMS; PLEURAL EFFUSION, MALIGNANT; PROGNOSIS; PROSPECTIVE STUDIES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; ROC CURVE; SENSITIVITY AND SPECIFICITY;

EID: 70349246883     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.24516     Document Type: Article

References (36)

1. Light RW. Diagnostic principles in pleural disease. Eur Respir J 1997;10:471-481
2. Maskell NA, Butland RJ. BTS guidelines for the investigation of a unilateral pleural effusion in adults. Thorax 2003;58:8-17.
3. Prakash UB, Reiman HM. Comparison of needle biopsy with cytologic analysis for the evaluation of pleural effusion: analysis of 414 cases. Mayo Clin Proc 1985;60:158-164
4. Tassi GF, Cardillo G, Marchetti GP, Carleo F, Martelli M. Diagnostic and therapeutical management of malignant pleural effusion. Annals of Oncology 2006;17:11-12
5. Porcel JM, Vives M, Esquerda A, Salud A, Pérez B, Rodríguez-Panadero F. Use of a panel of tumor markers (carcinoembryonic antigen, cancer antigen 125, carbohydrate antigen 15-3, and cytokeratin 19 fragments) in pleural fluid for the differential diagnosis of benign and malignant effusions. Chest 2004;126:1757-1763 (Pubitemid 39643976)
6. Light RW. Tumor markers in undiagnosed pleural effusions. Chest 2004;126:1721-1722 (Pubitemid 39643967)
7. Lo KW, Lo YM, Leung SF, Tsang YS, Chan LYS, Johnson PJ, Hjelm NM, Lee JC, Huang DP. Analysis of cell-free Epstein-Barr virus associated RNA in the plasma of patients with nasopharyngeal carcinoma. Clin Chem 1999;45:1292-1294 (Pubitemid 29424274)
8. Reddi KK, Holland JF. Elevated serum ribonuclease in patients with pancreatic cancer. Proc Natl Acad Sci USA 1976;73:2308-2310
9. Kopreski MS, Benko FA, Kwak LW, Gocke CD. Detection of tumor messenger RNA in the serum of patients with malignant melanoma. Clin Cancer Res 1999;5:1961-1965 (Pubitemid 29399244)
10. Chen XQ, Bonnefoi H, Pelte MF, Lyautey J, Lederrey C, Movarekhi S, Schaeffer P, Mulcahy HE, Meyer P, Stroun M, Anker P. Telomerase RNA as a detection marker in the serum of breast cancer patients. Clin Cancer Res 2000;6:3823-3826 (Pubitemid 30807069)
11. Silva JM, Dominguez G, Silva J, Garcia JM, Sanchez A, Rodriguez O, Provencio M, España P, Bonilla F. Detection of epithelial messenger RNA in the plasma of breast cancer patients is associated with poor prognosis tumor characteristics. Clin Cancer Res 2001;7:2821-2825
12. Fleischhacker M, Beinert T, Ermitsch M, Seferi D, Possinger K, Engelmann C, Jandrig B. Detection of amplifiable messenger RNA in the serum of patients with lung cancer. Ann N Y Acad Sci 2001;945:179-188 (Pubitemid 33022451)
13. Engel E, Schmidt B, Carstensen T, Weickmann S, Jandrig B, Witt C, Fleischhacker M. Detection of tumor-specific mRNA in cell-free bronchial lavage supernatant in patients with lung cancer. Ann NY Acad Sci 2004;1022:140-146 (Pubitemid 38951595)
14. Wang LF, Liu BR, Wang TT, Ding YT, Qian XP, Zhao Y. Detection of cell-free ERCC1 and thymdylate synthase (TS) mRNA in malignant effusions and its association with anticancer drug sensitivity. Anticancer Res 2008;28:1085-1092 (Pubitemid 351578958)
15. Altieri DC. Targeted therapy by disabling crossroad signaling networks: the survivin paradigm. Mol Cancer Ther 2006;5:478-482
16. Altieri DC. Survivin, versatile modulation of cell division and apoptosis in cancer. Oncogene 2003;22:8581-8589
17. Lee GH, Joo YE, Koh YS, Chung IJ, Park YK, Lee JH, Kim HS, Choi SK, Rew JS, Park CS, Kim SJ. Expression of survivin in gastric cancer and its relationship with tumor angiogenesis. Eur J Gastroenterol Hepatol 2006;18:957-963 (Pubitemid 44213038)
18. Akhtar M, Gallagher L, Rohan S. Survivin: role in diagnosis, prognosis, and treatment of bladder cancer. Adv Anat Pathol 2006;13:122-126 (Pubitemid 44341663)
19. Miyachi K, Sasaki K, Onodera S, Taguchi T, Nagamachi M, Kaneko H, Sunagawa M. Correlation between survivin mRNA expression and lymph node metastasis in gastric cancer. Gastric Cancer 2003;6:217-224 (Pubitemid 38140003)
20. Smith SD, Wheeler MA, Plescia J, Colberg JW, Weiss RM, Altieri DC. Urine detection of survivin and diagnosis of bladder cancer. JAMA 2001;285:324-328 (Pubitemid 32095036)
21. Vives M, Porcel JM, Vicente de Vera M, Ribelles E, Rubio M. A study of light's criteria and possible modifications for distinguishing exudative from transudative pleural effusions. Chest 1996;109:1503-1507 (Pubitemid 26193375)
22. Porcel JM, Vives M. Etiology and pleural fluid characteristics of large and massive effusions. Chest 2003;124:978-983 (Pubitemid 37123318)
23. Rana SV, Babu SG, Kocchar R. Usefulness of ascites fluid cholesterol as a marker for malignant ascites. Med Sci Monit 2005;11:136-142 (Pubitemid 40445987)
24. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 2001;25:402-408 (Pubitemid 34164012)
25. Akhtar M, Gallagher L, Rohan S. Survivin: role in diagnosis, prognosis, and treatment of bladder. Cancer Adv Anat Pathol 2006;13:122-126 (Pubitemid 44341663)
26. Shitrit D, Zingerman B, Shitrit AB, Shlomi D, Kramer MR. Diagnostic value of CYFRA-211. CEA, CA19-9, CA15-3, and CA125 assays in pleural effusions: analysis of 116 cases and review of the literature. Lung Cancer 2005;10:501-507
27. Alatas F, Alatas O, Metintas M, Colak O, Harmanci E, Demir S. Diagnostic value of CEA. CA 15-3, CA 19-9, CYFRA 21-1, NSE and TSA assay in pleural effusions. Lung Cancer 2001;31:9-16.
28. Hernandez L, Espasa A, Fernandez C, Candela A, Martín C, Romero S. CEA and CA 549 in serum and pleural fluid of patients with pleural effusion. Lung Cancer 2002;36:83-89 (Pubitemid 34224900)
29. Villena V, López-Encuentra A, Echave-Sustaeta J, Martín-Escribano P, Ortuño-de-Solo B, Estenoz-Alfaro J. Diagnostic value of CA 549 in pleural fluid: comparison with CEA. CA 15.3 and CA 72.4. Lung Cancer 2003;40:289-294
30. Swaminathan R, Butt AN. Circulating nucleic acids in plasma and serum: recent developments. Ann N Y Acad Sci 2006;1075:1-9. (Pubitemid 44532759)
31. Stroun M, Anker P, Maurice P, Lyautey J, Lederrey C, Beljanski M. Neoplastic characteristics of the DNA found in the plasma of cancer patients. Oncology 1989;46:318-322 (Pubitemid 19216753)
32. Sorenson GD, Pribish DM, Valone FH, Memoli VA, Bzik DJ, Yao SL. Soluble normal and mutated DNA sequences from single-copy genes in human blood. Cancer Epidemiol Biomarkers Prev 1994;3:67-71. (Pubitemid 24172525)
33. Vasioukhin V, Anker P, Maurice P, et al. Point mutations of the N-ras gene in the blood plasma DNA of patients with myelodysplastic syndrome or acute myelogenous leukaemia. Br J Haematol 1994;86:774-779 (Pubitemid 24194434)
34. Chen XQ, Stroun M, Magnenat JL, Nicod LP, Kurt AM, Lyautey J, Lederrey C, Anker P. Microsatellite alterations in plasma DNA of small cell lung cancer patients. Nat Med 1996;2:1033-1035 (Pubitemid 26306844)
35. Giacona MB, Ruben GC, Iczkowski KA, Roos TB, Porter DM, Sorenson GD. Cell-free DNA in human blood plasma: length measurements in patients with pancreatic cancer and healthy controls. Pancreas 1998;17:89-97.
36. Fournie GJ, Courtin JP, Laval F. Plasma DNA as a marker of cancerous cell death: investigation in patients suffering from lung cancer and in nude mice bearing human tumour. Cancer Lett 1995;2:221-227